Stock Market Today, Oct. 6: Marvell Stock Is Up as the Company Raises FY2028 Revenue Outlook to $20 Billion

Marvell raised its FY2028 revenue outlook to $20 billion from $18 billion and set FY2031 sales guidance of $70 billion to $90 billion, with an EPS target of at least $30. The targets reflect management's expectations for demand in custom AI chips and AI data-center networking; FY2026 diluted EPS was $3.07. Marvell shares closed up 5.81% at $287.01, on volume of 50.1 million shares—about 122% above the three-month average.

Analysis

The key market question is whether Marvell can convert long-dated ambition into durable, profitable programs—not whether AI infrastructure demand is real. The FY2028 raise is nearer-term evidence; the FY2031 sales and EPS targets require a much larger scale-up and should be treated as a scenario, not an earnings base case. Verify the revenue-to-EPS bridge, customer concentration, program ramps, and whether growth is organic before underwriting the out-year valuation.

Second-order effects cut both ways. MRVL’s custom silicon and connectivity exposure can capture spending that does not go to general-purpose accelerators, while broader custom-chip adoption could also reduce some customers’ reliance on merchant GPUs; NVIDIA’s partnership is strategically supportive but does not establish how economics or product substitution will net out. AVGO is a relevant custom-silicon competitor, while ANET is exposed to the same data-center buildout through networking demand. The read-through is positive for both, but not proof of equivalent earnings upside.

Near term (days), elevated volume after a sharp event-driven move raises the risk of profit-taking or a ‘sell the news’ response. Over 1–3 months, customer awards, disclosed program timing, and the next outlook update matter more than target headlines. Over 6–18 months, execution, customer capex durability, and margins will determine whether the guidance supports sustained multiple expansion. The contrarian risk is that investors capitalize the distant target before revenue visibility and the earnings bridge are independently demonstrated.

Key Decisions for Investors

• Avoid chasing the event-day move; consider adding MRVL only after consolidation or evidence in subsequent guidance that nearer-term program ramps support the FY2028 outlook. Falsifier: a guidance cut, delayed ramps, or weaker-than-expected custom-chip demand.
• Treat the FY2031 targets as an alert, not a base case. Before increasing long exposure, verify the revenue and EPS bridge, customer concentration, program commitments, and the assumed contribution from existing versus new customers.
• For relative exposure, monitor MRVL against AVGO rather than treating the entire AI-semi group as interchangeable. A widening MRVL underperformance alongside stable custom-silicon commentary would argue that execution or credibility—not sector demand—is the issue; do not initiate a valuation-based pair without current multiples and estimate data.
• Track ANET and broader data-center networking signals as a cross-check on infrastructure spending, but distinguish networking demand from MRVL-specific custom-silicon wins. A slowdown in customer capex or order commentary would weaken the sector read-through.